Ovarian steroid regulation of the midbrain corticotropin releasing factor and urocortin systems in macaques

Neuroscience

Volumn 171, Issue 3, 2010, Pages 893-909

  Sanchez, R L ^a   Reddy, A P ^a   Bethea, C L ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Corticotropin; Estrogen; Macaques; Progesterone; Serotonin; Urocortin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PLACEBO; PROGESTERONE; UROCORTIN I;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HORMONAL REGULATION; IMMUNOHISTOCHEMISTRY; MACACA; MESENCEPHALON; MOOD; NONHUMAN; PRIMATE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAPHE NUCLEUS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTONINERGIC NERVE CELL;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; GONADAL STEROID HORMONES; MACACA MULATTA; MESENCEPHALON; OVARY; PROGESTERONE; RAPHE NUCLEI; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; UROCORTINS;

EID: 78349312996     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.08.059     Document Type: Article

References (88)

1. Amat J., Tamblyn J.P., Paul E.D., Bland S.T., Amat P., Foster A.C., Watkins L.R., Maier S.F. Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala. Neuroscience 2004, 129:509-519.
2. Arango V., Underwood M.D., Mann J.J. Serotonin brain circuits involved in major depression and suicide. Prog Brain Res 2002, 136:443-453.
3. Austin M.C., Rice P.M., Mann J.J., Arango V. Localization of corticotropin-releasing hormone in the human locus coeruleus and pedunculopontine tegmental nucleus: an immunocytochemical and in situ hybridization study. Neuroscience 1995, 64:713-727.
4. Bao A.M., Hestiantoro A., Van Someren E.J., Swaab D.F., Zhou J.N. Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders. Brain 2005, 128:1301-1313.
5. Barbaccia M.L., Serra M., Purdy R.H., Biggio G. Stress and neuroactive steroids. Int Rev Neurobiol 2001, 46:243-272.
6. Bassett J.L., Foote S.L. Distribution of corticotropin-releasing factor-like immunoreactivity in squirrel monkey (Saimiri sciureus) amygdala. J Comp Neurol 1992, 323:91-102.
7. Behan D.P., De Souza E.B., Lowry P.J., Potter E., Sawchenko P., Vale W.W. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front Neuroendocrinol 1995, 16:362-382.
8. Behan D.P., Maciejewski D., Chalmers D., De Souza E.B. Corticotropin releasing factor binding protein (CRF-BP) is expressed in neuronal and astrocytic cells. Brain Res 1995, 698:259-264.
9. Bethea C.L. Colocalization of progestin receptors with serotonin in raphe neurons of macaque. Neuroendocrinology 1993, 57:1-6.
10. Bethea C.L. Regulation of progestin receptors in raphe neurons of steroid-treated monkeys. Neuroendocrinology 1994, 60:50-61.
11. Bethea C.L., Brown N.A., Kohama S.G. Steroid regulation of estrogen and progestin receptor messenger ribonucleic acid in monkey hypothalamus and pituitary. Endocrinology 1996, 137:4372-4383.
12. Bethea C.L., Centeno M.L. Ovarian steroid treatment decreases corticotropin-releasing hormone (CRH) mRNA and protein in the hypothalamic paraventricular nucleus of ovariectomized monkeys. Neuropsychopharmacology 2008, 33:546-556.
13. Bethea C.L., Lu N.Z., Gundlah C., Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 2002, 23:41-100.
14. Bethea C.L., Reddy A.P. Effect of ovarian hormones on survival genes in laser captured serotonin neurons from macaques. J Neurochem 2008, 105:1129-1143.
15. Bethea C.L., Reddy A.P. Effect of ovarian hormones on genes promoting dendritic spines in laser-captured serotonin neurons from macaques. Mol Psychiatry 2010, 15:1034-1044.
16. Bethea C.L., Reddy A.P., Smith L.J. Nuclear factor kappa B in the dorsal raphe of macaques: an anatomical link for steroids, cytokines and serotonin. J Psychiatry Neurosci 2006, 31:105-114.
17. Bethea C.L., Reddy A.P., Tokuyama Y., Henderson J.A., Lima F.B. Protective actions of ovarian hormones in the serotonin system of macaques. Front Neuroendocrinol 2009, 30:212-238.
18. Bethea C.L., Streicher J.M., Mirkes S.J., Sanchez R.L., Reddy A.P., Cameron J.L. Serotonin-related gene expression in female monkeys with individual sensitivity to stress. Neuroscience 2005, 132:151-166.
19. Bethea C.L., Widmann A.A. Differential espression of progestin receptor isoforms in the hypothalamus, pituitary, and endometrium or rhesus macaques. Endocrinology 1998, 139:677-687.
20. Centeno M.L., Sanchez R.L., Reddy A.P., Cameron J.L., Bethea C.L. Corticotropin-releasing hormone and pro-opiomelanocortin gene expression in female monkeys with differences in sensitivity to stress. Neuroendocrinology 2007, 86:277-288.
21. Cerillo G., Rees A., Manchanda N., Reilly C., Brogan I., White A., Needham M. The oestrogen receptor regulates NFkappaB and AP-1 activity in a cell-specific manner. J Steroid Biochem Mol Biol 1998, 67:79-88.
22. Chalmers D.T., Lovenberg T.W., De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 1995, 15:6340-6350.
23. Conde D.M., Pinto-Neto A.M., Santos-Sa D., Costa-Paiva L., Martinez E.Z. Factors associated with quality of life in a cohort of postmenopausal women. Gynecol Endocrinol 2006, 22:441-446.
24. Coplan JD, Abdallah CG, Kaufman J, Gelernter J, Smith EL, Perera TD, Dwork AJ, Kaffman A, Gorman JM, Rosenblum LA, Owens MJ, Nemeroff CB (in press) Early-life stress, corticotropin-releasing factor, and serotonin transporter gene: a pilot study. Psychoneuroendocrinology.
25. Dautzenberg F.M., Hauger R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 2002, 23:71-77.
26. Day H.E., Greenwood B.N., Hammack S.E., Watkins L.R., Fleshner M., Maier S.F., Campeau S. Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus. J Comp Neurol 2004, 474:364-378.
27. Dayas C.V., Xu Y., Buller K.M., Day T.A. Effects of chronic oestrogen replacement on stress-induced activation of hypothalamic-pituitary-adrenal axis control pathways. J Neuroendocrinol 2000, 12:784-794.
28. de Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005, 6:463-475.
29. Denihan A., Kirby M., Bruce I., Cunningham C., Coakley D., Lawlor B.A. Three-year prognosis of depression in the community-dwelling elderly. Br J Psychiatry 2000, 176:453-457.
30. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res Brain Res Rev 1990, 15:71-100.
31. Graeff F.G. On serotonin and experimental anxiety. Psychopharmacology (Berl) 2002, 163:467-476.
32. Gundlah C., Lu N.Z., Mirkes S.J., Bethea C.L. Estrogen receptor beta (ERb) mRNA and protein in serotonin neurons of macaques. Mol Brain Res 2001, 91:14-22.
33. Gundlah C., Pecins-Thompson M., Schutzer W.E., Bethea C.L. Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus. Mol Brain Res 1999, 63:325-339.
34. Hammack S.E., Richey K.J., Schmid M.J., LoPresti M.L., Watkins L.R., Maier S.F. The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress. J Neurosci 2002, 22:1020-1026.
35. Hanley N.R., Van de Kar L.D. Serotonin and the neuroendocrine regulation of the hypothalamic-pituitary-adrenal axis in health and disease. Vitam Horm 2003, 66:189-255.
36. Heikkinen J., Vaheri R., Timonen U. A 10-year follow-up of postmenopausal women on long-term continuous combined hormone replacement therapy: update of safety and quality-of-life findings. J Br Menopause Soc 2006, 12:115-125.
37. Hendricks T.J., Fyodorov D.V., Wegman L.J., Lelutiu N.B., Pehek E.A., Yamamoto B., Silver J., Weeber E.J., Sweatt J.D., Deneris E.S. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 2003, 37:233-247.
38. Himmerich H., Binder E.B., Kunzel H.E., Schuld A., Lucae S., Uhr M., Pollmacher T., Holsboer F., Ising M. Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Biol Psychiatry 2006, 60:882-888.
39. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res 1999, 33:181-214.
40. Keck M.E., Holsboer F. Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Peptides 2001, 22:835-844.
41. Keck M.E., Ohl F., Holsboer F., Muller M.B. Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders. Neurosci Biobehav Rev 2005, 29:867-889.
42. Kemp C.F., Woods R.J., Lowry P.J. The corticotrophin-releasing factor-binding protein: an act of several parts. Peptides 1998, 19:1119-1128.
43. Kostich W.A., Grzanna R., Lu N.Z., Largent B.L. Immunohistochemical visualization of corticotropin-releasing factor type 1 (CRF1) receptors in monkey brain. J Comp Neurol 2004, 478:111-125.
44. Kozicz T. Neurons colocalizing urocortin and cocaine and amphetamine-regulated transcript immunoreactivities are induced by acute lipopolysaccharide stress in the Edinger-Westphal nucleus in the rat. Neuroscience 2003, 116:315-320.
45. Kudielka B.M., Schmidt-Reinwald A.K., Hellhammer D.H., Kirschbaum C. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment. Neuroendocrinology 1999, 70:422-430.
46. Laflamme N., Nappi R.E., Drolet G., Labrie C., Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J Neurobiol 1998, 36:357-378.
47. Li X.F., Mitchell J.C., Wood S., Coen C.W., Lightman S.L., O'Byrne K.T. The effect of oestradiol and progesterone on hypoglycaemic stress-induced suppression of pulsatile luteinizing hormone release and on corticotropin-releasing hormone mRNA expression in the rat. J Neuroendocrinol 2003, 15:468-476.
48. Liebsch G., Landgraf R., Gerstberger R., Probst J.C., Wotjak C.T., Engelmann M., Holsboer F., Montkowski A. Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul Pept 1995, 59:229-239.
49. Lima F.B., Henderson J.A., Reddy A.P., Tokuyama Y., Hubert G.W., Kuhar M.J., Bethea C.L. Unique responses of midbrain CART neurons in macaques to ovarian steroids. Brain Res 2008, 1227:76-88.
50. Lowry C.A., Hale M.W., Plant A., Windle R.J., Shanks N., Wood S.A., Ingram C.D., Renner K.J., Lightman S.L., Summers C.H. Fluoxetine inhibits corticotropin-releasing factor (CRF)-induced behavioural responses in rats. Stress 2009, 12:225-239.
51. Luiten P.G., ter Horst G.J., Karst H., Steffens A.B. The course of paraventricular hypothalamic efferents to autonomic structures in medulla and spinal cord. Brain Res 1985, 329:374-378.
52. Lund T.D., Munson D.J., Haldy M.E., Handa R.J. Androgen inhibits, while oestrogen enhances, restraint-induced activation of neuropeptide neurones in the paraventricular nucleus of the hypothalamus. J Neuroendocrinol 2004, 16:272-278.
53. Maki P.M., Freeman E.W., Greendale G.A., Henderson V.W., Newhouse P.A., Schmidt P.J., Scott N.F., Shively C.A., Soares C.N. Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition. Menopause 2010, 17:815-822.
54. Mann J.J., Malone K.M., Diehl D.J., Perel J., Cooper T.B., Mintun M.A. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry 1996, 153:174-182.
55. May P.J., Reiner A.J., Ryabinin A.E. Comparison of the distributions of urocortin-containing and cholinergic neurons in the perioculomotor midbrain of the cat and macaque. J Comp Neurol 2008, 507:1300-1316.
56. KB and steroid receptor-signaling pathways. Endocr Rev 1999, 20:435-459.
57. Miller W.J., Suzuki S., Miller L.K., Handa R., Uht R.M. Estrogen receptor (ER)beta isoforms rather than ERalpha regulate corticotropin-releasing hormone promoter activity through an alternate pathway. J Neurosci 2004, 24:10628-10635.
58. Moncek F., Duncko R., Jezova D. Repeated citalopram treatment but not stress exposure attenuates hypothalamic-pituitary-adrenocortical axis response to acute citalopram injection. Life Sci 2003, 72:1353-1365.
59. Morimoto A., Nakamori T., Morimoto K., Tan N., Murakami N. The central role of corticotropin-releasing factor (CRF-41) in psychological stress in rats. J Physiol 1993, 460:221-229.
60. Muller M.B., Zimmermann S., Sillaber I., Hagemeyer T.P., Deussing J.M., Timpl P., Kormann M.S., Droste S.K., Kuhn R., Reul J.M., Holsboer F., Wurst W. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci 2003, 6:1100-1107.
61. Nemeroff C.B. Neurobiological consequences of childhood trauma. J Clin Psychiatry 65 2004, (Suppl 1):18-28.
62. Nemeroff C.C. Early-life adversity, CRF dysregulation, and vulnerability to mood and anxiety disorders. Psychopharmacol Bull 2004, 38:14-20.
63. Ni X., Nicholson R.C. Steroid hormone mediated regulation of corticotropin-releasing hormone gene expression. Front Biosci 2006, 11:2909-2917.
64. Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994, 40:288-295.
65. Pernar L., Curtis A.L., Vale W.W., Rivier J.E., Valentino R.J. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J Neurosci 2004, 24:1305-1311.
66. Petrov T., Krukoff T.L., Jhamandas J.H. The hypothalamic paraventricular and lateral parabrachial nuclei receive collaterals from raphe nucleus neurons: a combined double retrograde and immunocytochemical study. J Comp Neurol 1992, 318:18-26.
67. Portillo F., Carrasco M., Vallo J.J. Separate populations of neurons within the paraventricular hypothalamic nucleus of the rat project to vagal and thoracic autonomic preganglionic levels and express c-Fos protein induced by lithium chloride. J Chem Neuroanat 1998, 14:95-102.
68. Potter E., Behan D.P., Linton E.A., Lowry P.J., Sawchenko P.E., Vale W.W. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci U S A 1992, 89:4192-4196.
69. Raadsheer F.C., Hoogendijk W.J., Stam F.C., Tilders F.J., Swaab D.F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994, 60:436-444.
70. Ruggiero D.A., Underwood M.D., Rice P.M., Mann J.J., Arango V. Corticotropic-releasing hormone and serotonin interact in the human brainstem: behavioral implications. Neuroscience 1999, 91:1343-1354.
71. Sakai K., Salvert D., Touret M., Jouvet M. Afferent connections of the nucleus raphe dorsalis in the cat as visualized by the horseradish peroxidase technique. Brain Res 1977, 137:11-35.
72. Sakanaka M., Shibasaki T., Lederis K. Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method. J Comp Neurol 1987, 260:256-298.
73. Sanchez M.M., Young L.J., Plotsky P.M., Insel T.R. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J Comp Neurol 1999, 408:365-377.
74. Sanchez R.L., Reddy A.P., Centeno M.L., Henderson J.A., Bethea C.L. A second tryptophan hydroxylase isoform, TPH-2 mRNA, is increased by ovarian steroids in the raphe region of macaques. Brain Res Mol Brain Res 2005, 135:194-203.
75. Schule C., Baghai T.C., Eser D., Zwanzger P., Jordan M., Buechs R., Rupprecht R. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients. Psychopharmacology 2006, 186:601-611.
76. Smith G.W., Aubry J.M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., Chen R., Marchuk Y., Hauser C., Bentley C.A., Sawchenko P.E., Koob G.F., Vale W., Lee K.F. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998, 20:1093-1102.
77. Stout S.C., Owens M.J., Nemeroff C.B. Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment. J Pharmacol Exp Ther 2002, 300:1085-1092.
78. Stout S.C., Owens M.J., Nemeroff C.B. Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment. J Pharmacol Exp Ther 2002, 300:1085-1092.
79. Tangen T., Mykletun A. Depression and anxiety through the climacteric period: an epidemiological study (HUNT-II). J Psychosom Obstet Gynaecol 2008, 29:125-131.
80. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M., Stalla G.K., Blanquet V., Steckler T., Holsboer F., Wurst W. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 1998, 19:162-166.
81. Valdez G.R., Inoue K., Koob G.F., Rivier J., Vale W., Zorrilla E.P. Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Res 2002, 943:142-150.
82. Valentino R.J., Lucki I., Van Bockstaele E. Corticotropin-releasing factor in the dorsal raphe nucleus: linking stress coping and addiction. Brain Res 2009, 1314:29-37.
83. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 2000, 428:191-212.
84. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995, 378:287-292.
85. Weiss J.M., Stout J.C., Aaron M.F., Quan N., Owens M.J., Butler P.D., Nemeroff C.B. Depression and anxiety: role of the locus coeruleus and corticotropin releasing factor. Brain Res Bull 1994, 35:561-572.
86. Weissheimer K.V., Herod S.M., Cameron J.L., Bethea C.L. The role of stress sensitivity and the effect of citalopram treatment on corticotropin releasing hormone (CRH) and urocortin I (UCN) fiber density in the midbrain raphe region of macaques 2009, Society for Neuroscience, Chicago IL.
87. Weissheimer K.V., Herod S.M., Cameron J.L., Bethea C.L. Interactions of corticotropin-releasing factor, urocortin and citalopram in a primate model of stress-induced amenorhea. Neuroendocrinology 2010, [Epub ahead of print; PMID 20714124].
88. Xia-Zhang L., Xiao E., Ferin M. A 5-day estradiol therapy, in amounts reproducing concentrations of the early-mid follicular phase, prevents the activation of the hypothalamo-pituitary-adrenal axis by interleukin-1 alpha in the ovariectomized rhesus monkey. J Neuroendocrinol 1995, 7:387-392.